The Future of Oncology: How Public Policy, New Technology and Financial Considerations will Impact Cancer Care
With the U.S. healthcare system at an unprecedented crossroads, cancer care has emerged as one of the most hotly debated subjects. Stakeholders include manufacturers, physicians, patients, payers and service providers—even the government itself. And all have their own set of concerns to be addressed.
 | Join us as we discuss how crucial drivers like health reform, new technology and global economy converge to impact the oncology market. Pharmaceutical Executive Editor-in-Chief Bill Looney visits with Mark Santos, Executive Vice President and General Manager for ION, to discuss this complex industry:
- What can pharmaceutical manufacturers do to maintain product success?
- How can oncologists continue to provide quality care and manage operational costs?
- What role do payers play in the future of oncology?
Mark Santos
Executive Vice President and General Manager
ION
Interviewer: Bill Looney
| 
Add this Podcast feed to your media player
Click Here To Listen to More of the ABSG Podcast Series
|
Sponsored By  |
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
Applying E-Commerce to Support Discovery and Development of Medicines: Key Lessons and Learnings Tuesday, December 15 @ 11:00 a.m. ET
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?